Welcome to the Autumn issue of IPT! While October began with warm welcomes, the temperature is quickly dropping and the days are getting shorter as we brace for the end of the year. As the seasons change, it is the perfect time to reflect on all the latest technological innovations in the pharmaceutical industry.

CARBOGEN AMCIS kick of this issue with a spotlight showcasing the measures they have taken in making pharma manufacturing more sustainable (page 8). Following on from this is our Manufacturing section, featuring articles analysing why the healthcare sector must shift its focus from laboratory instrumentation to digital integration in order to bridge the gap between clinical diagnosis and laboratory in-sight (Salutare, page 12), and how protein quantitation can become flexible and transferable in order to support the way modern bioprocesses operate (Nirren, page 15). Ecolab discuss the rapid evolution of biologic therapeutics and how it is reshaping expectations for downstream process development (page 18).

Following on from this is IPT’s Digital section, where Thermo Fisher Scientific look into how lab-in-a-loop architectures are bringing scientific reasoning and automation together to accelerate biopharmaceutical research and development (page 20), and Nuclera look at how artificial intelligence is accelerating antibody design (page 24).

Astorium feature in our Lab Design section, discussing the expanding necessity to accommodate different capabilities of diversifying pharma pipelines in lab planning (page 28). Imaging and Sensing tackles the exciting topic of why ensuring accurate vessel pressure control can is essential for process quality (Burkert Fluid Control Systems, page 32).

Closing this issue is our Discovery and Design section, featuring a Q&A from LotusDx, discussing the challenges for accessible diagnostics for STI at home testing (page 36). Additionally, dsm-fermenich look at how to innovate by better understanding resources and molecules that are already possessed by looking at the value of vitamins to drug developers as multifunctional excipients (page 39).

I hope you enjoy our Autumn issue of IPT, our last one for 2026, and we look forward to welcoming you in the new year to see where the pharma landscape takes us in 2027.